Clover Biopharmaceuticals, Ltd.
Clover Biopharmaceuticals, Ltd. (HKSE: 2197) is trading at HK$2.05, about ₹25 at today's HKD/INR rate, as of 25 Sep 2026, 4:08 AM ET, down 0.73% today. Indian residents can buy Clover Biopharmaceuticals from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
HK$2.00
Today's high
HK$2.05
52 week low
HK$1.32
52 week high
HK$3.20
2197 opened at HK$2.02, closed previously at HK$2.06, and has traded between HK$1.32 and HK$3.20 over the past 52 weeks.
About
Clover Biopharmaceuticals, Ltd. is a biotechnology enterprise focused on discovering, developing, and commercializing innovative vaccines and biological therapies. Their efforts target infectious diseases, various cancers, and autoimmune conditions. The company's pipeline features several key candidates: SCB-2019 (CpG 1018/Alum): A COVID-19 vaccine candidate currently advancing through Phase II/III clinical trials. SCB-313: A trimeric fusion protein aimed at treating severe intracavitary malignancies, including malignant ascites, malignant pleural effusions, and peritoneal carcinomatosis, addressing a significant global medical need. SCB-808: Undergoing pivotal Phase III clinical trials for the management of rheumatic disorders. SCB-420: An aflibercept biosimilar in preclinical development for ophthalmologic conditions like wet age-related macular degeneration. SCB-219: A novel TPOR agonist in preclinical stages for the treatment of chemotherapy-induced thrombocytopenia and immune thrombocytopenic purpura. Clover also holds a collaboration and supply agreement with Dynavax, which provides its CpG 1018 adjuvant for use in preclinical studies. The company was established in 2007 and is based in Shanghai, China.
Key statistics
Avg. volume
4.54M
Market cap
HK$2.65B
P/E Ratio
2.65
Price-to-sales ratio
5356.56
Enterprise value
CN¥2.18B
Free cash flow yield
-3.51%
Debt-to-equity ratio
-0.00
Return on equity
-64.89%
ROIC
-425.76%
Beta
2.57
Dividend yield
0.00%
Last dividend
HK$0.00
Financial overview
Revenue
CN¥3.41M
Earnings per share
-CN¥0.16
Free cash flow
-CN¥190.55M
Net profit margin
199197.33%
Gross margin
-9099.11%
EBITDA
-CN¥221.24M
Revenue growth
-91.11%
Similar securities
This is not an investment recommendation
How to buy Clover Biopharmaceuticals from India
Indian residents can buy Clover Biopharmaceuticals shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.
Search for Clover Biopharmaceuticals and place an order
Find Clover Biopharmaceuticals by name or by its ticker, 2197, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. Clover Biopharmaceuticals trades 7:00 am – 1:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Clover Biopharmaceuticals position in HKD and INR. Clover Biopharmaceuticals pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Clover Biopharmaceuticals from India
Trading and taxes when buying Clover Biopharmaceuticals from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm HKT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneClover Biopharmaceuticals does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Clover Biopharmaceuticals stock?
Yes. Clover Biopharmaceuticals (2197) has been listed on the Hong Kong Stock Exchange since 2021, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Clover Biopharmaceuticals share cost in rupees?
One Clover Biopharmaceuticals share is HK$2.05 — about ₹25 at an HKD/INR rate of 12.23 on 25 Sep 2026. Both the Clover Biopharmaceuticals price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Clover Biopharmaceuticals from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of Clover Biopharmaceuticals?
Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
How are gains on Clover Biopharmaceuticals shares taxed in India?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Clover Biopharmaceuticals price. Paasa issues a capital-gains statement for your return.
Does Clover Biopharmaceuticals pay a dividend?
No. Clover Biopharmaceuticals does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Clover Biopharmaceuticals from India?
The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.
Is Clover Biopharmaceuticals a Hong Kong SAR China company, and does that change how it is taxed?
Clover Biopharmaceuticals trades on the Hong Kong Stock Exchange in HKD, but the company is domiciled in China. Clover Biopharmaceuticals trades as an ordinary share listed directly in Hong Kong, not a depositary receipt. Your India-side capital-gains treatment is the same either way.
Do I have to declare Clover Biopharmaceuticals shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Clover Biopharmaceuticals holding, its cost and its closing value.
How do I sell Clover Biopharmaceuticals and bring the money back to India?
You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.